BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7578849)

  • 1. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II.
    Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA
    Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
    Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
    Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.
    Grubin CE; Daniels T; Toivola B; Landin-Olsson M; Hagopian WA; Li L; Karlsen AE; Boel E; Michelsen B; Lernmark A
    Diabetologia; 1994 Apr; 37(4):344-50. PubMed ID: 8063033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585).
    Teoh KL; Fida S; Rowley MJ; Mackay IR
    Autoimmunity; 1998; 28(4):259-66. PubMed ID: 9892508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes.
    Lühder F; Schlosser M; Mauch L; Haubruck H; Rjasanowski I; Michaelis D; Kohnert KD; Ziegler M
    Autoimmunity; 1994; 19(2):71-80. PubMed ID: 7772705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
    Daw K; Powers AC
    Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients.
    Hou J; Said C; Franchi D; Dockstader P; Chatterjee NK
    Diabetes; 1994 Oct; 43(10):1260-6. PubMed ID: 7523207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
    Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes.
    Falorni A; Grubin CE; Takei I; Shimada A; Kasuga A; Maruyama T; Ozawa Y; Kasatani T; Saruta T; Li L
    Autoimmunity; 1994; 19(2):113-25. PubMed ID: 7772701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reactivity to GAD25 in type 1 diabetes mellitus.
    Chessler SD; Hampe CS; Ortqvist E; Simonson WT; Bekris L
    Autoimmunity; 2002 Aug; 35(5):335-41. PubMed ID: 12515288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.